Disease | hepatosplenic t-cell lymphoma |
Phenotype | C0021390|inflammatory bowel disease |
Sentences | 3 |
PubMedID- 22890223 | The rare occurrence of hepatosplenic t-cell lymphomas in inflammatory bowel disease patients is associated with thiopurine immunomodulatory therapy (azathioprine or 6-mercaptopurine), used either as monotherapy or in combination with tnf-α antagonists (7,11,12). |
PubMedID- 20888436 | A systematic review of factors that contribute to hepatosplenic t-cell lymphoma in patients with inflammatory bowel disease. |
PubMedID- 20927075 | hepatosplenic t-cell lymphoma in inflammatory bowel disease: a possible thiopurine-induced chromosomal abnormality. |
Page: 1